DENORA, NUNZIO
 Distribuzione geografica
Continente #
NA - Nord America 17.680
AS - Asia 7.664
EU - Europa 7.193
SA - Sud America 1.881
Continente sconosciuto - Info sul continente non disponibili 957
AF - Africa 316
OC - Oceania 34
Totale 35.725
Nazione #
US - Stati Uniti d'America 17.307
SG - Singapore 2.989
IT - Italia 2.621
CN - Cina 1.765
BR - Brasile 1.451
HK - Hong Kong 948
SE - Svezia 917
RU - Federazione Russa 768
DE - Germania 677
FI - Finlandia 512
VN - Vietnam 504
FR - Francia 429
GB - Regno Unito 392
UA - Ucraina 318
IN - India 252
BD - Bangladesh 251
ID - Indonesia 226
CA - Canada 176
AR - Argentina 154
IQ - Iraq 118
JP - Giappone 96
MX - Messico 88
NL - Olanda 86
TR - Turchia 84
ZA - Sudafrica 84
CI - Costa d'Avorio 68
ES - Italia 68
BE - Belgio 67
PK - Pakistan 65
PL - Polonia 64
EC - Ecuador 63
CO - Colombia 62
AT - Austria 61
VE - Venezuela 60
IE - Irlanda 53
SA - Arabia Saudita 46
CZ - Repubblica Ceca 38
MA - Marocco 36
PY - Paraguay 35
MY - Malesia 31
PH - Filippine 31
AU - Australia 30
UZ - Uzbekistan 29
JO - Giordania 24
LT - Lituania 24
TH - Thailandia 23
CL - Cile 22
KE - Kenya 21
IR - Iran 20
TN - Tunisia 20
JM - Giamaica 19
KR - Corea 18
DZ - Algeria 17
EG - Egitto 17
CR - Costa Rica 16
AZ - Azerbaigian 15
NP - Nepal 15
AE - Emirati Arabi Uniti 14
KZ - Kazakistan 13
RO - Romania 13
UY - Uruguay 13
ET - Etiopia 12
PE - Perù 12
PT - Portogallo 11
BH - Bahrain 10
HN - Honduras 10
OM - Oman 10
BO - Bolivia 9
BY - Bielorussia 9
CH - Svizzera 9
GT - Guatemala 9
LB - Libano 9
TT - Trinidad e Tobago 9
NI - Nicaragua 8
DO - Repubblica Dominicana 7
IL - Israele 7
NG - Nigeria 7
PS - Palestinian Territory 7
AL - Albania 6
MD - Moldavia 6
MK - Macedonia 6
PA - Panama 6
QA - Qatar 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
EE - Estonia 5
KG - Kirghizistan 5
RS - Serbia 5
DK - Danimarca 4
GD - Grenada 4
GE - Georgia 4
HR - Croazia 4
KW - Kuwait 4
LY - Libia 4
PR - Porto Rico 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
YE - Yemen 4
BG - Bulgaria 3
Totale 34.704
Città #
Ashburn 1.764
Singapore 1.622
Fairfield 1.503
Chandler 1.260
San Jose 1.125
Woodbridge 1.002
Hong Kong 935
Houston 830
Jacksonville 708
Milan 695
Nyköping 673
Seattle 635
Cambridge 602
Beijing 518
Wilmington 504
Ann Arbor 483
Council Bluffs 414
New York 390
Bari 347
Dallas 308
Helsinki 305
Los Angeles 281
Lawrence 248
Lauterbourg 246
Roxbury 242
Nanjing 218
Rome 211
Boardman 189
Brooklyn 164
Santa Clara 153
Des Moines 147
Ho Chi Minh City 137
Princeton 134
São Paulo 133
Hanoi 126
Jakarta 118
Munich 110
Chicago 104
Columbus 95
Buffalo 85
London 85
Grottaglie 80
Frankfurt am Main 75
Falkenstein 70
Abidjan 68
San Diego 68
Brussels 66
Inglewood 64
Tokyo 63
Baghdad 62
Dong Ket 57
San Francisco 57
Figino 56
Bitonto 54
Shenyang 53
Warsaw 53
Hebei 51
Dublin 50
Montreal 50
Nuremberg 50
Jiaxing 49
Denver 48
Nanchang 46
Orem 46
Turin 46
Atlanta 44
Rio de Janeiro 44
Johannesburg 43
Moscow 43
Turku 43
Tianjin 42
Paris 41
Bitetto 40
Amsterdam 39
Falls Church 39
Toronto 39
Phoenix 38
Belo Horizonte 36
The Dalles 35
Guangzhou 34
Vienna 34
Washington 34
Napoli 32
Chennai 31
Naples 30
Shanghai 30
Stockholm 30
Boston 29
Guayaquil 29
Mexico City 29
Elk Grove Village 28
Hangzhou 28
Mumbai 26
Salt Lake City 26
Brasília 25
Tashkent 25
Wuhan 25
Changsha 24
Dearborn 24
Haiphong 24
Totale 22.394
Nome #
Boric Acid, a Lewis Acid With Unique and Unusual Properties: Formulation Implications 331
S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery 320
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 297
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base 278
Grape seed extracts modify the outcome of oxaliplatin in colon cancer cells by interfering with cellular mechanisms of drug cytotoxicity 265
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 262
Spray-dried mucoadhesives for intravesical drug delivery using N-acetylcysteine- and glutathione-glycol chitosan conjugates 253
Lipid-based systems loaded with PbS nanocrystals: near infrared emitting trackable nanovectors 251
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 247
Preactivated thiolated glycogen as mucoadhesive polymer for drug delivery 247
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery 231
NIR Emitting Nanoprobes Based on Cyclic RGD Motif Conjugated PbS Quantum Dots for Integrin-Targeted Optical Bioimaging 223
2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line. 222
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 219
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 214
Exploring Basic Tail Modifications of Coumarin-based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-soluble, Brain-permeant Neuroprotective Multitarget Agents 208
A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells 205
Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors 200
Principi di calcolo farmaceutico 199
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 199
Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration 199
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 198
Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO. 195
Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases 195
Antitumor Potential of Conjugable Valinomycins Bearing Hydroxyl Sites: In Vitro Studies 192
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 192
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders 191
Delivery of proapoptotic agents in glioma cell lines by TSPO ligand–dextran nanogels 191
A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO) 190
Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml 187
New Azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity 186
Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment 185
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 185
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 183
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer 183
Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3 181
FZD10 Carried by Exosomes Sustains Cancer Cell Proliferation 178
Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization. 175
Quantum Dot Based Luminescent Nanoprobes for Sigma-2 Receptor Imaging 173
Automated identification of structurally heterogeneous and patentable antiproliferative hits as potential tubulin inhibitors 173
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 173
One pot environmental friendly synthesis of Gold Nanoparticles using Punica Granatum Juice: a novel antioxidant agent for future dermatological and cosmetic applications. 172
Some Preformulation Studies of Pyruvic Acid and Other α-Keto Carboxylic Acids in Aqueous Solution: Pharmaceutical Formulation Implications for These Peroxide Scavengers 172
Contact allergy to electrocardiogram electrodes caused by acrylic acid without sensitivity to methacrylates and ethyl cyanoacrylate 172
Effect Of Diazoxide on Friedreich Ataxia Models 171
TSPO ligand-methotrexate prodrug conjugates: Design, synthesis, and biological evaluation 170
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles 170
2-Phenyl-imidazo[1,2-a]pyridine compounds containing hydrophilic groups as potent and selective ligands for peripheral benzodiazepine receptors: synthesis, binding affinity and electrophysiological studies 169
N-benzyl-2-(6,8-dichloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3yl)-N(6-(7-nitrobenzo[c][1,2,5]oxadiazol-4-ylamino)hexyl)acetamide as a new fluorescentprobe for peripheral benzodiazepine receptor and microglialcell visualization 169
Novel chemotypes targeting tubulin at the Colchicine binding site and unbiasing P-glycoprotein 168
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 168
The Complexity of the Blood-Brain Barrier and the Concept of Age-Related Brain Targeting: Challenges and Potential of Novel Solid Lipid-Based Formulations 168
Imaging modification of colon carcinoma cells exposed to lipid based nanovectors for drug delivery: a scanning electron microscopy investigation 167
Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs. 165
Synthesis and Biological Evaluation of a Valinomycin Analog Bearing a Pentafluorophenyl Active Ester Moiety 164
Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing glutathione 162
Searching for Multitargeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE−MAO B Inhibitors through the Decoration of 2H-Chromen-2-one Structural Motif 162
Anticoagulant activity of new glycoconjugated inhibitors Of factor Xa and thrombin 162
b-Cyclodextrin in personal care formulation: role on the complexation of malodors causing molecules 158
Biotin-decorated silica coated PbS nanocrystals emitting in the second biological near infrared window for bioimaging 158
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate 158
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 158
Bortezomib Aqueous Solubility in the Presence and Absence of D-Mannitol: A Clarification With Formulation Implications 158
New biodegradable hydrogels based on inulin and α,β-polyaspartylhydrazide designed for colonic drug delivery: in vitro release of glutathione and oxytocin 156
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 155
Enzymatic Resolution of α-Methyleneparaconic Acids and Evaluation of their Biological Activity 154
AZEPINO [4,3-b]INDOLE DERIVATIVES AS SELECTIVE INHIBITORS OF HUMAN BUTYRYLCHOLINESTERASE WITH PROTECTIVE EFFECTS AGAINST NMDA-INDUCED NEUROTOXICITY 152
Colonic budesonide delivery by multistimuli alginate/Eudragit® FS 30D/inulin-based microspheres as a paediatric formulation 150
A rapid screening tool for estimating the potential of 2-hydroxypropyl-beta-cyclodextrin complexation for solubilization purposes 150
Thiolated polymeric hydrogels for biomedical application: Cross-linking mechanisms 149
Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery 149
Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [11C]CB184 and [11C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [11C](R)-PK11195 148
Transferrin Functionalized Liposomes Loading Dopamine HCl: Development and Permeability Studies across an In Vitro Model of Human Blood-Brain Barrier 147
Characterization and release studies of liposomal gels containing glutathione/cyclodextrins complexes potentially useful for cutaneous administration 147
Chiral Separation, X-ray Structure, and Biological Evaluation of a Potent and Reversible Dual Binding Site AChE Inhibitor 147
Direct cyclodextrin based powder extrusion 3D printing of budesonide loaded mini-tablets for the treatment of eosinophilic colitis in paediatric patients 143
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 143
B-CYCLODEXTRIN IN PERSONAL CARE FORMULATION: ROLE ON THE COMPLEXATION OF MALODORS CAUSING MOLECULES 142
Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position 142
Novel L-dopa and dopamine prodrugs containing a 2-phenyl-imidazopyridine moiety 142
Antiplatelet 2-Hydroxy Thienopyridine Ester Derivatives for the Reduction of Thrombotic Cardiovascular Events 142
Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery 141
Site-dependent biological activity of valinomycin analogs bearing derivatizable hydroxyl sites 141
CAT microscopy: a novel tool for 3D cell investigation 140
Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 139
Comparative effect of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations 137
Translocator Protein Ligand-PLGA conjugates nanoparticles for 5-Fluorouracil Delivery to Glioma Cancer Cells 136
An updated view of translocator protein (TSPO) 135
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 135
Nanoformulations for drug delivery: safety, toxicity, and efficacy 135
Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery 134
Biological Evaluation Of Some Peripheral Benzodiazepine Receptor Ligand Cytarabine Conjugates For Selective Delivery To Human Lymphoma 134
Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor 134
Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone Ophthalmic Delivery System for Anti-Inflammatory Therapy 133
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 133
Microfluidic development of brain-derived neurotrophic factor loaded solid lipid nanoparticles: An in vitro evaluation in the post-traumatic brain injury neuroinflammation model 131
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer 131
A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor 129
TSPO-targeted NIR-fluorescent ultra-small iron oxide nanoparticles for glioblastoma imaging 129
beta-Cyclodextrin in personal care formulation: role on the complexation of malodours causing molecules 128
Totale 17.630
Categoria #
all - tutte 145.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.810 0 0 34 40 85 180 95 81 202 271 289 533
2022/20233.291 489 402 219 280 383 419 57 380 483 43 92 44
2023/20241.417 88 201 88 89 161 389 70 83 24 31 31 162
2024/20255.952 230 102 410 205 216 517 744 533 243 358 845 1.549
2025/202612.404 1.593 570 804 1.244 1.271 649 1.444 413 1.423 1.207 471 1.315
2026/20271.553 582 570 401 0 0 0 0 0 0 0 0 0
Totale 35.725